Cargando…
Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: a good deal?
BACKGROUND: Glioblastoma (GB) is the most malignant brain tumor in adults. It is characterized by angiogenesis and a high proliferative and invasive capacity. Standard therapy (surgery, radiotherapy and chemotherapy with temozolomide) is of limited efficacy. Innovative anticancer drugs targeting bot...
Autores principales: | Clavreul, Anne, Pourbaghi-Masouleh, Milad, Roger, Emilie, Lautram, Nolwenn, Montero-Menei, Claudia N., Menei, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622550/ https://www.ncbi.nlm.nih.gov/pubmed/28962658 http://dx.doi.org/10.1186/s13046-017-0605-2 |
Ejemplares similares
-
Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far
por: Clavreul, Anne, et al.
Publicado: (2019) -
Development and characterization of sorafenib-loaded lipid nanocapsules for the treatment of glioblastoma
por: Clavreul, Anne, et al.
Publicado: (2018) -
Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules
por: Clavreul, Anne, et al.
Publicado: (2015) -
Mesenchymal Stromal-Like Cells in the Glioma Microenvironment: What Are These Cells?
por: Clavreul, Anne, et al.
Publicado: (2020) -
A Combinatorial Cell and Drug Delivery Strategy for Huntington’s Disease Using Pharmacologically Active Microcarriers and RNAi Neuronally-Committed Mesenchymal Stromal Cells
por: André, Emilie M., et al.
Publicado: (2019)